Insider Buying: Molina Healthcare, Inc (NYSE:MOH) COO Purchases 10,000 Shares of Stock

Key Points

• James Woys, COO of Molina Healthcare, purchased 10,000 shares of the stock for approximately $1.56 million, increasing his stake in the company by 15.54%.
• Molina Healthcare reported an earnings per share (EPS) of $5.48 for the last quarter, missing estimates by $0.02, while its revenue increased by 15.7% year-over-year.
• Analysts have adjusted their target prices for Molina Healthcare, with estimates now ranging from $180 to $244.55, indicating a generally cautious outlook.

Molina Healthcare, Inc (NYSE:MOH - Get Free Report) COO James Woys purchased 10,000 shares of the stock in a transaction dated Monday, August 4th. The shares were purchased at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the transaction, the chief operating officer owned 74,331 shares in the company, valued at approximately $11,591,176.14. The trade was a 15.54% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Molina Healthcare Stock Performance

NYSE MOH traded down $2.84 during trading hours on Wednesday, hitting $152.40. The company had a trading volume of 1,289,293 shares, compared to its average volume of 2,282,350. The business has a 50 day moving average of $245.64 and a 200-day moving average of $289.80. The company has a market cap of $8.26 billion, a PE ratio of 7.51 and a beta of 0.52. Molina Healthcare, Inc has a 1-year low of $151.95 and a 1-year high of $365.23. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to analyst estimates of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The firm's revenue for the quarter was up 15.7% compared to the same quarter last year. During the same period last year, the company earned $5.86 earnings per share. As a group, equities research analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on MOH. UBS Group cut their target price on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Truist Financial reiterated a "hold" rating and issued a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. Wells Fargo & Company cut their target price on Molina Healthcare from $372.00 to $216.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 23rd. JPMorgan Chase & Co. cut their price objective on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating on the stock in a report on Tuesday, July 29th. Finally, Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $244.55.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Price T Rowe Associates Inc. MD increased its stake in Molina Healthcare by 46.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock valued at $1,264,214,000 after purchasing an additional 1,216,903 shares during the period. FMR LLC increased its stake in Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after purchasing an additional 427,276 shares during the period. T. Rowe Price Investment Management Inc. increased its stake in Molina Healthcare by 8.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company's stock valued at $490,099,000 after purchasing an additional 117,796 shares during the period. Invesco Ltd. increased its stake in Molina Healthcare by 28.5% in the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after purchasing an additional 294,180 shares during the period. Finally, AQR Capital Management LLC increased its stake in Molina Healthcare by 42.7% in the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company's stock valued at $288,125,000 after purchasing an additional 264,664 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.